Research Topics
| Olaf JohnellSummaryCountry: Sweden Publications
| Collaborators
|
Detail Information
Publications
Latitude, socioeconomic prosperity, mobile phones and hip fracture riskO Johnell
Department of Orthopaedics, Malmo University Hospital, Malmo, Sweden
Osteoporos Int 18:333-7. 2007..Epidemiological observations suggest that sunlight exposure is an important determinant of hip fracture risk. The aim of this ecological study was to examine the relationship between latitude and hip fracture probability...
[The value of bone density measurement--a follow-up of the conclusions in the earlier SBU report]O Johnell
Ortopedkirurgiska kliniken, Universitetssjukhuset i Malmö
Lakartidningen 97:4113-6. 2000..The best risk assessment is achieved by taking into account both clinical risk factors and bone density...
Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapyOlaf Johnell
Department of Orthopedics, Universitetssjukhuset MAS, SE 20502 Malmo, Sweden
J Fam Pract 53:789-96. 2004..We examined whether past use of hormone therapy influences the effects of raloxifene on the risk of new vertebral fracture, cardiovascular events, or breast cancer...
Economic implication of osteoporotic spine disease: cost to societyOlof Johnell
Department of Orthopaedics, Malmo University Hospital, 205 02, Malmo, Sweden
Eur Spine J 12:S168-9. 2003..These new data on the cost of vertebral fractures will have an impact on health economy calculations. In the future it may be be cost-effective only to prevent vertebral fractures...
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide TurbuhalerO Johnell
Dept of Orthopaedics, Malmo University Hospital, Sweden
Eur Respir J 19:1058-63. 2002....
Clinical usefulness of bone mineral density and the health economy consequences of osteoporosisO Johnell
Department of Orthopaedics, Malmo University Hospital, Malmo, Sweden
Horm Res 54:64-7. 2000..Health economic studies have shown that the treatment of these high-risk patients is cost-effective...
No association between inhaled corticosteroids and whole body DXA in postmenopausal womenSolve Elmstahl
Division of Geriatric Medicine, Department of Health Sciences, Lund University, Malmo, Sweden
Pharmacoepidemiol Drug Saf 15:527-35. 2006..Postmenopausal women treated with corticosteroids are regarded as a high-risk group due to the effect of both natural bone loss and possible adverse effects of treatment with inhaled corticosteroids (IC)...
Epidemiology of osteoporotic fracturesOlof Johnell
Department of Orthopaedics, , Sweden
Osteoporos Int 16:S3-7. 2005..55; for men aged 50-54 years, the incidence of hip fractures should be multiplied by 4.48, and for those aged 80-84 years by 1.50...
Long term effects of oestrogen therapy on bone loss in postmenopausal women: a 23 year prospective studyHenrik G Ahlborg
Department of Orthopaedics, , Sweden
BJOG 111:335-9. 2004..8 percentage points (95% CI 0.2-1.4). CONCLUSIONS: The use of oestrogen seems to reduce the rate of bone loss over a period of 23 years, and the longer the duration of the therapy, the less bone loss...
An age-related medullary expansion can have implications for the long-term fixation of hip prosthesesHenrik G Ahlborg
Department of Orthopedics, Malmo University Hospital, SE 205 02 Malmo, Sweden
Acta Orthop Scand 75:154-9. 2004..Since the menopause is followed by an increase in bone loss, the size of the medullary cavity should theoretically increase during the postmenopausal period. If so, this might affect the long-term fixation of hip prostheses...
Forearm bone mineral density in 1294 middle-aged women: a strong predictor of fragility fracturesAnna Holmberg
Department of Orthopaedics, Malmo University Hospital, SE 205 02 Malmo, Sweden
J Clin Densitom 7:419-23. 2004....
Predictive value of BMD for hip and other fracturesOlof Johnell
Department of Orthopaedics, Malmo University Hospital, Malmo, Sweden
J Bone Miner Res 20:1185-94. 2005..Its validation on an international basis permits its use in case finding strategies. Its use should, however, take account of the variations in predictive value with age and BMD...
Non-participants differ from participants as regards risk factors for vertebral deformities: a source of misinterpretation in the European Vertebral Osteoporosis StudyRalph Hasserius
Department of Orthopaedics, Malmo University Hospital, Sweden
Acta Orthop Scand 73:451-4. 2002..In women, it is more difficult to estimate the combined result of the confounding factors. Conclusions based on the EVOS participants may not be applicable to the whole population at risk...
Costs of internal fixation and arthroplasty for displaced femoral neck fractures: a randomized study of 68 patientsCecilia Rogmark
Department of Orthopaedics, Malmo University Hospital, SE 205 02 Malmo, Sweden
Acta Orthop Scand 74:293-8. 2003..Considering the very much higher failure rate after internal fixation--leading to increased suffering for these patients--primary arthroplasty stands out as the best method for displaced fractures of the femoral neck...
Bone loss and bone size after menopauseHenrik G Ahlborg
Department of Orthopedics, Malmo University Hospital, Malmo, Sweden
N Engl J Med 349:327-34. 2003..Whether bone size increases as a result of periosteal apposition and whether a strength index accounting for both bone density and bone size might predict the risk of fracture better than bone density alone are unclear...
Vertebroplasty and kyphoplasty in the fractured osteoporotic spineAcke Ohlin
Department of Orthopaedics, , Lund University
Clin Calcium 14:65-9. 2004..There is however a disturbing lack of scientific evidence regarding the efficacy of the procedures, no controlled studies are published. An ongoing prospective randomised study is presented...
Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) StudyOlof Johnell
Department of Orthopaedics, , Malm, Sweden
J Bone Miner Res 19:764-72. 2004..006) and lower LS BMD values (p = 0.008) at baseline. These data suggest that the efficacy of raloxifene in reducing vertebral fractures is largely independent of the presence of clinical risk factors for osteoporotic fractures...
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fracturesOlof Johnell
Department of Orthopedics, , Malm, Sweden
Pharmacoeconomics 21:305-14. 2003..However, the costs per QALY gained for all populations studied were below generally accepted thresholds for cost effectiveness...
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosisOlof Johnell
Department of Orthopaedics, Universiteitssjukhuset MAS, Malm, Sweden
J Clin Endocrinol Metab 87:985-92. 2002..RLX+ALN reduced bone turnover more than either drug alone, resulting in greater BMD increment, but whether this difference reflects better fracture risk reduction was not assessed in this study...
Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and womenAnna H Holmberg
Department of Orthopaedics, Lund University, Malmo University Hospital, 20502, Malmo, Sweden
Osteoporos Int 16:2185-94. 2005..The findings indicate that those suffering a hip fracture before the age of 75 have a shorter life expectancy, suggesting that hip fractures affect the less healthy segment of the population...
Costs and quality of life associated with osteoporosis-related fractures in SwedenFredrik Borgstrom
Medical Management Centre, Karolinska Institutet, Stockholm, Sweden
Osteoporos Int 17:637-50. 2006....
Alcohol intake as a risk factor for fractureJohn A Kanis
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK
Osteoporos Int 16:737-42. 2005..We conclude that reported intake of alcohol confers a risk of some importance beyond that explained by BMD. The validation of this risk factor on an international basis permits its use in case-finding strategies...
A meta-analysis of milk intake and fracture risk: low utility for case findingJohn A Kanis
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK
Osteoporos Int 16:799-804. 2005..We conclude that a self-reported low intake of milk is not associated with any marked increase in fracture risk and that the use of this risk indicator is of little or no value in case-finding strategies...
Evidence from data searches and life-table analyses for gender-related differences in absolute risk of hip fracture after Colles' or spine fracture: Colles' fracture as an early and sensitive marker of skeletal fragility in white menPatrick Haentjens
Department of Orthopaedics and Traumatology, Vrije Universiteit Brussel, Brussels, Belgium
J Bone Miner Res 19:1933-44. 2004..The gender-related differences reported in this analysis should be taken into account when designing screening and treatment strategies for prevention of hip fracture in men...
Long-term cost and effect on quality of life of osteoporosis-related fractures in SwedenOskar Ström
Innovus, Stockholm, Sweden
Acta Orthop 79:269-80. 2008..This prospective observational data collection study assessed the cost and quality of life related to hip, vertebral, and wrist fracture 13-18 months after the fracture, based on 684 patients surviving 18 months after fracture...
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE studyFredrik Borgstrom
Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden
Pharmacoeconomics 22:1153-65. 2004..The Multiple Outcomes of Raloxifene Evaluation (MORE) study showed that treatment with raloxifene reduces the risk of vertebral fracture and breast cancer in postmenopausal women with osteoporosis...
Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fractureMary L Bouxsein
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
J Am Acad Orthop Surg 12:385-95. 2004..Thus, they have the unique opportunity to serve as primary advocates to ensure that appropriate action is taken to reduce the risk of future fracture...
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster
Osteoporos Int 17:1-7. 2006....
Potential impact of osteoporosis treatment on hip fracture trendsL Joseph Melton
J Bone Miner Res 20:895-7. 2005
Intervention thresholds for osteoporosis in the UKJohn A Kanis
Centre for Metabolic Bone Diseases WHO Collaborating Centre, University of Sheffield Medical School, Sheffield, UK
Bone 36:22-32. 2005....
Multinational survey of osteoporotic fracture managementKarsten E Dreinhöfer
Department of Orthopaedics, Rehabilitationskrankenhaus, Ulm University, Germany
Osteoporos Int 16:S44-53. 2005..Development of a simple clinical pathway from evidence-based guidelines is an important step to ensure that optimal care is provided for patients with fragility fractures...
The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approachChris De Laet
Department of Public Health, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Osteoporos Int 16:313-8. 2005..Case-finding strategies that combine clinical risk indicators with BMD have increased efficiency, while having a modest impact on the number of individuals requiring treatment. Therefore, the cost-effectiveness is enhanced...
Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trialJohn A Kanis
WHO Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK
Bone 33:293-300. 2003....
Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysisMartina Dören
Free University of Berlin, Clinical Research Center of Women s Health, Klingsorst 109a, D 12203 Berlin, Germany
Hum Reprod 18:1737-46. 2003....
[Final reply on bone density measurement in the heel: Diagnosis of osteoporosis should be done by DXA-measurement in the hip and spine]Osten Ljunggren
Medicinkliniken, Akademiska sjukhuset, Uppsala
Lakartidningen 100:539-40. 2003
Is there an association between inhaled corticosteroids and bone density in postmenopausal women?Solve Elmstahl
Division of Geriatric Medicine, Department of Community Medicine, Lund University, Sweden
J Allergy Clin Immunol 111:91-6. 2003..During the last decades, there has been increased concern about the association between oral corticosteroid (OC) therapy and osteoporosis...
Risk factors for incident vertebral fractures in men and women: the Rotterdam StudyMarjolein van der Klift
Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands
J Bone Miner Res 19:1172-80. 2004..In women, early menopause, current smoking, and walking aid use are additional independent risk factors for incident vertebral fractures...
Intervention thresholds for osteoporosis in men and women: a study based on data from SwedenJohn A Kanis
Centre for Metabolic Bone Diseases WHO Collaborating Centre, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK
Osteoporos Int 16:6-14. 2005....
Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS SwedenDan Mellstrom
Center for Bone Research, Departments of Internal Medicine and Geriatrics at the Sahlgrenska Academy The Sahlgrenska Academy at Göteborg University, Goteborg, Sweden
J Bone Miner Res 21:529-35. 2006..We show that free testosterone within the normal range is a predictor of BMD at predominantly cortical bone sites and of previous osteoporosis-related fractures in elderly Swedish men...
Incidence of hospitalized osteoporotic fractures in cohorts with high dietary intake of persistent organochlorine compoundsAnn-Kathrine Alveblom
Department of Occupational and Environmental Medicine, Lund University Hospital, 221 85 Lund, Sweden
Int Arch Occup Environ Health 76:246-8. 2003..To clarify this, detailed individual information on exposure and potential confounders has to be ascertained...
The epidemiology of total hip replacement in The Netherlands and Sweden: present status and future needsMarieke Ostendorf
Department of Orthopaedics, University Medical Center Utrecht, The Netherlands
Acta Orthop Scand 73:282-6. 2002..Assuming no further change in the age- and sex-specific arthroplasty rates, the predicted annual number of total hip replacements by the year 2020 will increase by at least one fourth in Sweden and almost one half in The Netherlands...
International variations in hip fracture probabilities: implications for risk assessmentJohn A Kanis
WHO Collaborating Center for Metabolic Bone Diseases, University of Sheffield Medical School, United Kingdom
J Bone Miner Res 17:1237-44. 2002..The categorization of hip fracture probabilities can be used to adjust intervention thresholds based on age, sex, and relative risk from a reference population such as Sweden...
The perspective of the international osteoporosis foundation on the official positions of the international society for clinical densitometryJohn A Kanis
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, S10 2DU, Sheffield, UK
J Clin Densitom 8:145-7. 2005
Excess mortality after hospitalisation for vertebral fractureJohn A Kanis
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, S10 2RX, Sheffield, UK
Osteoporos Int 15:108-12. 2004..We conclude that a minority of deaths following hospitalization for vertebral fracture are attributable to the fracture itself under the assumptions we used...
Cost effectiveness of alendronate for the treatment of male osteoporosis in SwedenFredrik Borgstrom
Stockholm Health Economics, Sweden
Bone 34:1064-71. 2004..Similar effects of alendronate were observed in men in some other trials. There are also results demonstrating alendronate to be cost-effective in the treatment of osteoporosis in women...
Whole lotta shakin' goin' onOlof Johnell
J Bone Miner Res 19:1205-7. 2004
Optimization of BMD measurements to identify high risk groups for treatment--a test analysisHelena Johansson
Statistician, Romelanda, Sweden
J Bone Miner Res 19:906-13. 2004..These findings need to be validated in other cohorts at different ages and from different regions of the world...
Osteoporosis and the global competition for health care resourcesL Joseph Melton
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Bone Miner Res 19:1055-8. 2004..To better compete for these resources, efforts should be made to lower the cost of osteoporosis interventions. Additionally, evidence is needed that these interventions are really effective in reducing fractures in the community...
Assessment of fracture riskJohn A Kanis
Centre for Metabolic Bone Diseases WHO Collaborating Centre, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, UK
Osteoporos Int 16:581-9. 2005..Treatment can then be offered to those identified to have a fracture probability greater than an intervention threshold...
A meta-analysis of prior corticosteroid use and fracture riskJohn A Kanis
Centre for Metabolic Bone Diseases WHO Collaborating Centre, University of Sheffield Medical School, Sheffield, United Kingdom
J Bone Miner Res 19:893-9. 2004..Current and past use of corticosteroids was an important predictor of fracture risk that was independent of prior fracture and BMD...
A retrospective analysis of health care costs for bone fractures in women with early-stage breast carcinomaZhiyuang Zhou
Global Outcomes Research, Pharmacia Corporation, Bridgewater, New Jersey, USA
Cancer 100:507-17. 2004..Additional research should include appropriate, incidence-based studies to investigate the potential benefit of an intervention for preventing bone fracture in this increasingly large patient population...
The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical DensitometryJohn A Kanis
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield S10 2DU, UK
Osteoporos Int 16:456-9, discussion 579-80. 2005
The economic cost of low back pain in Sweden in 2001Mattias Ekman
Stockholm Health Economics, SE 111 21 Stockholm, Sweden
Acta Orthop 76:275-84. 2005..The magnitude of LBP as a health problem justifies a closer look at its burden of illness to society...
